# Shake Shack Inc.: financial statements, quarterly

SHAK · NYSE · CIK 1620533 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/shak.md) · [Financials](/companies/shak/financials.md) · [Filings](/companies/shak/filings.md) · [Insiders](/companies/shak/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/shak/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-27) | Q4 FY2023 (2023-12-27) | Q1 FY2024 (2024-03-27) | Q2 FY2024 (2024-06-26) | Q3 FY2024 (2024-09-25) | Q4 FY2024 (2024-12-25) | Q1 FY2025 (2025-03-26) | Q2 FY2025 (2025-06-25) | Q3 FY2025 (2025-09-24) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-01) | Q2 FY2026 (2026-07-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [276](/filings/0001620533-24-000110.md) | [286 d](/filings/0001620533-26-000018.md) | [291](/filings/0001620533-25-000029.md) | [316](/filings/0001620533-25-000065.md) | [317](/filings/0001620533-25-000075.md) | [329 d](/filings/0001620533-26-000018.md) | [321](/filings/0001620533-26-000026.md) | [356](/filings/0001620533-26-000034.md) | [367](/filings/0001620533-25-000075.md) | [401 d](/filings/0001620533-26-000018.md) | [367](/filings/0001620533-26-000026.md) | [418](/filings/0001620533-26-000034.md) |
| Operating income | $m | [5.7](/filings/0001620533-24-000110.md) | [(1.3) d](/filings/0001620533-26-000018.md) | [0.0](/filings/0001620533-25-000029.md) | [10.8](/filings/0001620533-25-000065.md) | [(18.0)](/filings/0001620533-25-000075.md) | [10.2 d](/filings/0001620533-26-000018.md) | [2.8](/filings/0001620533-26-000026.md) | [22.4](/filings/0001620533-26-000034.md) | [18.5](/filings/0001620533-25-000075.md) | [18.7 d](/filings/0001620533-26-000018.md) | [(2.6)](/filings/0001620533-26-000026.md) | [20.7](/filings/0001620533-26-000034.md) |
| Interest expense | $m | [0.4](/filings/0001620533-24-000110.md) | [0.5 d](/filings/0001620533-26-000018.md) | [0.5](/filings/0001620533-25-000029.md) | [0.5](/filings/0001620533-25-000065.md) | [0.5](/filings/0001620533-25-000075.md) | [0.5 d](/filings/0001620533-26-000018.md) | [0.6](/filings/0001620533-26-000026.md) | [0.5](/filings/0001620533-26-000034.md) | [0.5](/filings/0001620533-25-000075.md) | [0.5 d](/filings/0001620533-26-000018.md) | [0.5](/filings/0001620533-26-000026.md) | [0.6](/filings/0001620533-26-000034.md) |
| Income tax | $m | [0.5](/filings/0001620533-24-000110.md) | [(5.8) d](/filings/0001620533-26-000018.md) | [0.5](/filings/0001620533-25-000029.md) | [3.2](/filings/0001620533-25-000065.md) | [(3.9)](/filings/0001620533-25-000075.md) | [3.6 d](/filings/0001620533-26-000018.md) | [0.7](/filings/0001620533-26-000026.md) | [6.2](/filings/0001620533-26-000034.md) | [7.4](/filings/0001620533-25-000075.md) | [8.5 d](/filings/0001620533-26-000018.md) | [(0.1)](/filings/0001620533-26-000026.md) | [5.9](/filings/0001620533-26-000034.md) |
| Net income | $m | [7.6](/filings/0001620533-24-000110.md) | [7.2 d](/filings/0001620533-26-000018.md) | [2.0](/filings/0001620533-25-000029.md) | [9.7](/filings/0001620533-25-000065.md) | [(10.2)](/filings/0001620533-25-000075.md) | [8.7 d](/filings/0001620533-26-000018.md) | [4.2](/filings/0001620533-26-000026.md) | [17.1](/filings/0001620533-26-000034.md) | [12.5](/filings/0001620533-25-000075.md) | [11.8 d](/filings/0001620533-26-000018.md) | [(0.3)](/filings/0001620533-26-000026.md) | [15.7](/filings/0001620533-26-000034.md) |
| Diluted EPS | $ per share | [0.19](/filings/0001620533-24-000110.md) | not reported | [0.05](/filings/0001620533-25-000029.md) | [0.23](/filings/0001620533-25-000065.md) | [(0.26)](/filings/0001620533-25-000075.md) | not reported | [0.10](/filings/0001620533-26-000026.md) | [0.41](/filings/0001620533-26-000034.md) | [0.30](/filings/0001620533-25-000075.md) | not reported | [(0.01)](/filings/0001620533-26-000026.md) | [0.37](/filings/0001620533-26-000034.md) |
| Basic EPS | $ per share | [0.19](/filings/0001620533-24-000110.md) | not reported | [0.05](/filings/0001620533-25-000029.md) | [0.24](/filings/0001620533-25-000065.md) | [(0.26)](/filings/0001620533-25-000075.md) | not reported | [0.11](/filings/0001620533-26-000026.md) | [0.43](/filings/0001620533-26-000034.md) | [0.31](/filings/0001620533-25-000075.md) | not reported | [(0.01)](/filings/0001620533-26-000026.md) | [0.39](/filings/0001620533-26-000034.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-27) | FY2023 (2023-12-27) | Q1 FY2024 (2024-03-27) | Q2 FY2024 (2024-06-26) | Q3 FY2024 (2024-09-25) | FY2024 (2024-12-25) | Q1 FY2025 (2025-03-26) | Q2 FY2025 (2025-06-25) | Q3 FY2025 (2025-09-24) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-01) | Q2 FY2026 (2026-07-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [190](/filings/0001620533-24-000023.md) | [225](/filings/0001620533-25-000016.md) | [260](/filings/0001620533-24-000040.md) | [302](/filings/0001620533-24-000086.md) | [311](/filings/0001620533-24-000110.md) | [321](/filings/0001620533-26-000018.md) | [313](/filings/0001620533-25-000029.md) | [337](/filings/0001620533-25-000065.md) | [358](/filings/0001620533-25-000075.md) | [360](/filings/0001620533-26-000034.md) | [314](/filings/0001620533-26-000026.md) | [308](/filings/0001620533-26-000034.md) |
| Current assets | $m | [323](/filings/0001620533-24-000023.md) | [334](/filings/0001620533-25-000016.md) | [326](/filings/0001620533-24-000040.md) | [346](/filings/0001620533-24-000086.md) | [354](/filings/0001620533-24-000110.md) | [368](/filings/0001620533-26-000018.md) | [365](/filings/0001620533-25-000029.md) | [391](/filings/0001620533-25-000065.md) | [415](/filings/0001620533-25-000075.md) | [430](/filings/0001620533-26-000034.md) | [394](/filings/0001620533-26-000026.md) | [394](/filings/0001620533-26-000034.md) |
| Total assets | $m | [1,582](/filings/0001620533-24-000023.md) | [1,606](/filings/0001620533-25-000016.md) | [1,619](/filings/0001620533-24-000040.md) | [1,662](/filings/0001620533-24-000086.md) | [1,675](/filings/0001620533-24-000110.md) | [1,697](/filings/0001620533-26-000018.md) | [1,727](/filings/0001620533-25-000029.md) | [1,775](/filings/0001620533-25-000065.md) | [1,827](/filings/0001620533-25-000075.md) | [1,896](/filings/0001620533-26-000034.md) | [1,918](/filings/0001620533-26-000026.md) | [1,950](/filings/0001620533-26-000034.md) |
| Current liabilities | $m | [152](/filings/0001620533-24-000023.md) | [164](/filings/0001620533-25-000016.md) | [161](/filings/0001620533-24-000040.md) | [168](/filings/0001620533-24-000086.md) | [176](/filings/0001620533-24-000110.md) | [187](/filings/0001620533-26-000018.md) | [191](/filings/0001620533-25-000029.md) | [204](/filings/0001620533-25-000065.md) | [225](/filings/0001620533-25-000075.md) | [245](/filings/0001620533-26-000034.md) | [233](/filings/0001620533-26-000026.md) | [236](/filings/0001620533-26-000034.md) |
| Total liabilities | $m | [1,123](/filings/0001620533-24-000023.md) | [1,136](/filings/0001620533-25-000016.md) | [1,147](/filings/0001620533-24-000040.md) | [1,175](/filings/0001620533-24-000086.md) | [1,196](/filings/0001620533-24-000110.md) | [1,203](/filings/0001620533-26-000018.md) | [1,230](/filings/0001620533-25-000029.md) | [1,256](/filings/0001620533-25-000065.md) | [1,292](/filings/0001620533-25-000075.md) | [1,342](/filings/0001620533-26-000034.md) | [1,363](/filings/0001620533-26-000026.md) | [1,379](/filings/0001620533-26-000034.md) |
| Long-term debt | $m | [245](/filings/0001620533-24-000023.md) | [246](/filings/0001620533-25-000016.md) | [246](/filings/0001620533-24-000040.md) | [246](/filings/0001620533-24-000086.md) | [246](/filings/0001620533-24-000110.md) | [247](/filings/0001620533-26-000018.md) | [247](/filings/0001620533-25-000029.md) | [247](/filings/0001620533-25-000065.md) | [247](/filings/0001620533-25-000075.md) | [248](/filings/0001620533-26-000034.md) | [248](/filings/0001620533-26-000026.md) | [248](/filings/0001620533-26-000034.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [433](/filings/0001620533-24-000023.md) | [443](/filings/0001620533-25-000016.md) | [446](/filings/0001620533-24-000040.md) | [462](/filings/0001620533-24-000086.md) | [456](/filings/0001620533-24-000110.md) | [470](/filings/0001620533-26-000018.md) | [473](/filings/0001620533-25-000029.md) | [494](/filings/0001620533-25-000065.md) | [509](/filings/0001620533-25-000075.md) | [525](/filings/0001620533-26-000034.md) | [526](/filings/0001620533-26-000026.md) | [544](/filings/0001620533-26-000034.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-27) | Q4 FY2023 (2023-12-27) | Q1 FY2024 (2024-03-27) | Q2 FY2024 (2024-06-26) | Q3 FY2024 (2024-09-25) | Q4 FY2024 (2024-12-25) | Q1 FY2025 (2025-03-26) | Q2 FY2025 (2025-06-25) | Q3 FY2025 (2025-09-24) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-01) | Q2 FY2026 (2026-07-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [28.4 d](/filings/0001620533-24-000110.md) | [41.5 d](/filings/0001620533-26-000018.md) | [30.7](/filings/0001620533-25-000029.md) | [53.5 d](/filings/0001620533-25-000065.md) | [41.9 d](/filings/0001620533-25-000075.md) | [45.1 d](/filings/0001620533-26-000018.md) | [31.2](/filings/0001620533-26-000026.md) | [65.0 d](/filings/0001620533-26-000034.md) | [63.0 d](/filings/0001620533-25-000075.md) | [63.1 d](/filings/0001620533-26-000018.md) | [8.5](/filings/0001620533-26-000026.md) | [57.0 d](/filings/0001620533-26-000034.md) |
| Capital expenditure | $m | [38.3 d](/filings/0001620533-24-000110.md) | [33.1 d](/filings/0001620533-26-000018.md) | [33.1](/filings/0001620533-25-000029.md) | [32.9 d](/filings/0001620533-25-000065.md) | [34.8 d](/filings/0001620533-25-000075.md) | [34.7 d](/filings/0001620533-26-000018.md) | [29.4](/filings/0001620533-26-000026.md) | [38.1 d](/filings/0001620533-26-000034.md) | [39.3 d](/filings/0001620533-25-000075.md) | [59.2 d](/filings/0001620533-26-000018.md) | [47.2](/filings/0001620533-26-000026.md) | [57.7 d](/filings/0001620533-26-000034.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-28) | Q1 FY2023 (2023-03-29) | Q2 FY2023 (2023-06-28) | Q3 FY2023 (2023-09-27) | Q1 FY2024 (2024-03-27) | Q2 FY2024 (2024-06-26) | Q3 FY2024 (2024-09-25) | Q1 FY2025 (2025-03-26) | Q2 FY2025 (2025-06-25) | Q3 FY2025 (2025-09-24) | Q1 FY2026 (2026-04-01) | Q2 FY2026 (2026-07-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.3](/filings/0001620533-24-000023.md) | [39.3](/filings/0001620533-24-000040.md) | [43.9](/filings/0001620533-24-000086.md) | [44.0](/filings/0001620533-24-000110.md) | [41.3](/filings/0001620533-25-000029.md) | [41.5](/filings/0001620533-25-000065.md) | [40.0](/filings/0001620533-25-000075.md) | [41.9](/filings/0001620533-26-000026.md) | [41.8](/filings/0001620533-26-000034.md) | [41.9](/filings/0001620533-25-000075.md) | [40.3](/filings/0001620533-26-000026.md) | [41.9](/filings/0001620533-26-000034.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. No prices; not investment advice.